IRIS
FERAGALLI, Beatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.497
AS - Asia 4.104
EU - Europa 3.533
SA - Sud America 677
Continente sconosciuto - Info sul continente non disponibili 584
AF - Africa 60
OC - Oceania 58
AN - Antartide 1
Totale 20.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.241
SG - Singapore 1.717
CN - Cina 962
IT - Italia 651
IE - Irlanda 551
BR - Brasile 530
RU - Federazione Russa 420
UA - Ucraina 382
VN - Vietnam 376
SE - Svezia 365
TR - Turchia 329
GB - Regno Unito 308
DE - Germania 235
FR - Francia 199
IN - India 168
HK - Hong Kong 158
CA - Canada 115
ES - Italia 68
FI - Finlandia 67
AU - Australia 56
BD - Bangladesh 55
AR - Argentina 50
JP - Giappone 42
AT - Austria 41
MX - Messico 40
NL - Olanda 40
PL - Polonia 38
BE - Belgio 37
ID - Indonesia 35
TH - Thailandia 29
TW - Taiwan 29
EC - Ecuador 28
PT - Portogallo 27
CO - Colombia 26
IR - Iran 25
IQ - Iraq 24
KR - Corea 23
MY - Malesia 23
ZA - Sudafrica 21
CR - Costa Rica 19
PK - Pakistan 19
CZ - Repubblica Ceca 15
LT - Lituania 14
PH - Filippine 14
TT - Trinidad e Tobago 14
IL - Israele 13
JM - Giamaica 13
VE - Venezuela 12
CL - Cile 11
NI - Nicaragua 11
RO - Romania 11
CH - Svizzera 10
EE - Estonia 9
PY - Paraguay 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
JO - Giordania 8
EU - Europa 7
GR - Grecia 7
SC - Seychelles 7
GT - Guatemala 6
HN - Honduras 6
MA - Marocco 6
PA - Panama 6
SV - El Salvador 6
UZ - Uzbekistan 6
HR - Croazia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BB - Barbados 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
KE - Kenya 4
MK - Macedonia 4
PR - Porto Rico 4
SI - Slovenia 4
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CG - Congo 2
GP - Guadalupe 2
KW - Kuwait 2
ME - Montenegro 2
MM - Myanmar 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
Totale 19.915
Salva come PNG Salva come JPEG
Città #
Singapore 1.211
San Jose 676
Chandler 661
Ashburn 570
Jacksonville 560
Dublin 535
Dallas 334
Princeton 251
Beijing 239
Council Bluffs 238
Los Angeles 236
Santa Clara 216
New York 193
Izmir 160
Nanjing 154
Ho Chi Minh City 143
Hong Kong 122
Wilmington 116
Southend 115
Altamura 104
The Dalles 98
Hanoi 94
Atlanta 90
North Bergen 82
Cambridge 80
Ann Arbor 74
Dearborn 67
Orem 64
San Francisco 64
Denver 62
Phoenix 60
Buffalo 59
Nanchang 58
Chieti 56
Boardman 48
Redondo Beach 48
Brooklyn 44
Milan 43
Seattle 43
São Paulo 38
Frankfurt am Main 36
Moscow 36
Tongling 36
Columbus 35
Munich 33
Tokyo 33
Boston 32
Catania 32
Houston 32
Shenyang 31
Kunming 30
Montreal 30
Hebei 29
Memphis 29
Chennai 28
Mount Pleasant 27
Toronto 27
Washington 27
London 26
Menlo Park 26
Chicago 24
Falls Church 24
Tianjin 23
Brussels 22
Sydney 22
Woodbridge 22
Warsaw 21
Amsterdam 20
Jiaxing 20
Naples 20
Norwalk 20
Rio de Janeiro 20
Rome 20
Istanbul 19
Santa Pola 19
Vienna 19
Da Nang 18
Hangzhou 17
Kuala Lumpur 17
Manchester 17
Mumbai 16
Pescara 16
Curitiba 15
Silver Spring 15
Taichung 15
Changsha 14
Helsinki 14
Johannesburg 14
San José 14
Shanghai 14
Stockholm 14
Haiphong 13
Nuremberg 13
Stoke-on-Trent 13
Calpe 12
Mexico City 12
Paris 12
Taipei 12
Vilnius 12
Ankara 11
Totale 9.396
Salva come PNG Salva come JPEG
Nome #
Chronic venous insufficiency and venous microangiopathy: Management with compression and Pycnogenol® 902
Supplementation with a new food grade delivery system of Boswellia and Centella in the intervertebral discs registry: The Sager study 724
Central Cardiovascular Calcifications: Supplementation With Pycnogenol® and Centellicum®: Variations Over 12 Months 694
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 683
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 559
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 445
Hangover and fatigue: effects of Robuvit® supplementation. A pilot registry study. 406
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 365
Effects of different doses of Pycnogenol® on plasma oxidative stress: A pilot, supplement study 359
Pycnogenol® prevents oxidative stress and side effects in patients with hypothyroidism during levothyroxine treatment 342
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 300
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry 295
Improvement of common cold with Pycnogenol®: a Winter registry study 243
Cone beam computed tomography for dental and maxillofacial imaging: technique improvement and low-dose protocols 229
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 223
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 223
Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization 200
[Possibility of false negative results in the diagnosis of lung neoplasms with computerized tomography] 195
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol® 194
Pulmonary nodule [Il nodulo polmonare] 191
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 181
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 175
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 175
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 170
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 169
Biomechanical aspects in late implant failures: Scanning electron microscopy analysis of four clinical cases 167
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 165
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 165
Robuvit®: improvement of fatigue in medical convalescence. 164
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 159
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 159
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 158
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 158
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 158
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 156
Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit® 155
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 154
Mononucleosis-related fatigue: supplementary management with Robuvit®. 154
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 151
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 147
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 147
Management of symptoms, pain and mobility with supplementary managements (including Movardol Forte) in osteoarthrosis: A 6-month, morphology supplement study 147
Anatomical features of cephalothoracopagus variations: CT and MRI. 145
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 145
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 144
Ecografia toracica. Diagnosi e tecniche interventistiche 141
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 141
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 140
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 139
Assessment of aortic valve area (AVA) by cardiac magnetic resonance (CMR) imaging in comparison with transthoracic (TTE) and transesophageal echocardiography (TEE) 137
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 136
Valutazione dell'area valvolare aortica (AVA): confronto fra risonanza cardiaca (RCM), ecocardiografiatranstoracia (ETT) e transesofagea (ETE) 135
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 134
Non-small cell lung carcinoma. Early diagnosis: applicability of a screening 134
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 134
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 134
Pycnogenol® supplementation in minimal cognitive dysfunction 133
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 132
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 131
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 130
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 130
Malignant pleural disease 128
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 127
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 126
7T mMR in the assessment of acute arterial mesenteric ischemia in a rat model 126
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 124
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 123
Radiographic evaluation of mediastinal lines as a diagnostic approach to occult or subtle mediastinal abnormalities. 122
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 122
Small-Bowel Neoplasms: Role of MRI Enteroclysis 122
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 121
Improvement of common cold with Pycnogenol®: a Winter registry study. 120
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 120
Primary benign back pain: supplementation with Pycnogenol® 119
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 118
Errors in imaging of traumatic injuries 118
A sport cream (Harpago-Boswellia-ginger-escin) for localized neck/shoulder pain 118
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 115
Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing 115
Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study 115
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. 113
Pulmonary nodule. 113
Prevalence of Ponticulus Posticus and Migraine in 220 Orthodontic Patients: A Cross-Sectional Study 111
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study 111
Malignant pleural disease 110
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 110
Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide 110
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 109
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 109
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 107
Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study 107
Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: Use and limitations 105
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 103
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 103
Thoracic ultrasound in children: evidence and drawbacks 101
Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19) 101
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 100
Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study 100
Pycnogenol® supplementation improves cognitive function, attention and mental performance in students.SourceIrvine3 Labs, Department of Biomedical Sciences Chieti - Pescara University, Pescara, Italy. 99
Pycnogenol® improvements in asthma management. 99
Totale 18.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022502 0 0 0 0 75 38 20 48 36 22 72 191
2022/20231.869 179 268 93 201 162 355 113 153 210 25 74 36
2023/20241.007 57 40 75 32 57 223 250 54 41 56 34 88
2024/20252.585 158 528 418 76 102 103 47 140 350 132 213 318
2025/20265.472 324 176 554 705 458 292 708 339 520 414 284 698
2026/20275.557 1.154 1.666 1.204 1.297 236 0 0 0 0 0 0 0
Totale 20.514